Boothbay Fund Management, LLC Haemonetics Corp Transaction History

Boothbay Fund Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$81.24 - $97.37 $1.05 Million - $1.25 Million	12,881 Added 84.2%	28,179 $2.33 Million
Q1 2024 May 15, 2024	BUY	$71.24 - $85.35 $1.09 Million - $1.31 Million	15,298 New	15,298 $1.31 Million
Q1 2023 May 15, 2023	BUY	$72.75 - $90.6 $11,058 - $13,771	152 Added 5.87%	2,740 $226,000
Q4 2022 Feb 14, 2023	BUY	$73.85 - $86.14 $191,123 - $222,930	2,588 New	2,588 $203,000
Q3 2021 Nov 15, 2021	SELL	$57.6 - $70.59 $1.07 Million - $1.31 Million	-18,604 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$51.81 - $118.56 $830,617 - $1.9 Million	16,032 Added 623.33%	18,604 $1.24 Million
Q1 2021 May 17, 2021	BUY	$111.01 - $139.48 $285,517 - $358,742	2,572 New	2,572 $286,000

334

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.54B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.